Kelly Holman

Invests in

Biotech

Investments

Per the firm's website.

Colleagues at Genesys Capital

BS

Benjamin Silbert

Principal at Calera Capital

CT

Christine Thoburn

Office Manager at Genesys Capital

DL

Damian Lamb

Co-Founder, Managing Partner at Genesys Capital

JS

Jamie Stiff

Managing Director at Genesys Capital

JW

Jennifer Williams

CFO at Genesys Capital

LM

Laurie Mak

Associate at Genesys Capital

LL

Lisa Low

Senior Vice President, Finance at Genesys Capital

PS

Paras Sharma

Senior Associate at Genesys Capital

Frequently asked questions

Who is Kelly Holman?

Kelly Holman co-founded Genesys Capital in 2000 and serves as Managing Director, bringing commercial and technical experience in biotechnology. He has helped raise over $400 million in venture capital and deploy it across 41 investments. Before Genesys, he was a Senior Investment Manager at MDS Capital Corporation and previously worked in Dr. Peter St George-Hyslop's laboratory at the University of Toronto on Alzheimer's disease genetics research. He holds an honours BSc in Biochemistry and an MBA from Queen's University.

Where does Kelly Holman work?

Kelly Holman is Co-founder, Managing Director at Genesys Capital.

What does Kelly Holman invest in?

Kelly Holman invests in Biotech.

What boards does Kelly Holman sit on?

Kelly Holman holds tracked board seats at Adapsyn Bioscience Inc., Epocal, Functional Neuromodulation Ltd., Questat Inc..

Where did Kelly Holman go to school?

Kelly Holman studied at Queen's University (MBA); Queen's University (Bachelor of Science (Honours), Biochemistry); LPCI.